Platelet activation plays a pro-inflammatory role in myasthenia gravis

Myasthenia gravis (MG) is an autoimmune disorder that disrupts neuromuscular junction function through autoantibodies. Platelets are emerging as key players in the pathogenesis of MG, bridging innate and adaptive immunity. We analyze platelet transcriptome signatures and their interactions with the immune system in AChR+ immunotherapy-naïve MG (nMG) patients using bulk and single-cell RNA sequencing on peripheral blood mononuclear cells (PBMC). nMG patients exhibit upregulation of genes related to activation, inflammation, and cytoskeletal regulation. Increased platelet count, activation, altered morphology, enhanced CD62P expression, and elevated plasma CD40L levels are observed in PBMCs, which diminish with minimal clinical status (MMS). Functionally, platelets show heightened interactions with leukocytes, forming aggregates that correlate with disease severity. These features return to baseline after intravenous immunoglobulin or prolonged immunosuppressive therapy. This study underscores platelet activation's critical role in MG and supports platelet-targeted therapy.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-10-02
DOI
https://doi.org/10.1038/s41467-025-63750-2
Citations
4
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
5.56

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Platelet activation plays a pro-inflammatory role in myasthenia gravis

Shufang Zhao, Rui‐Sheng Duan, Jianying Duo, Wenjia Zhu et al.
4 citations
Nature Communications
Myasthenia Gravis and Thymoma
5.56
article

Platelet activation plays a pro-inflammatory role in myasthenia gravis

Shufang Zhao, Rui‐Sheng Duan, Jianying Duo, Wenjia Zhu, Yaye Wang, Junwei Hao, Shengyao Su, Nairong Xie, Yuwei Da, Dongshan Wan, Haoran Liu, Guoliang Chai, Xinmei Wen, Suobin Wang, Y. Huang, Xiaoli Li, Shu Zhang, Di Li, Min Xu, Hai Chen, Lu Yan, Zhen Tao, Jingsi Wang, Jinming Han, Q. G. Wen, Wanting Lu, Min Wang
article en
4 citations

Abstract

Myasthenia gravis (MG) is an autoimmune disorder that disrupts neuromuscular junction function through autoantibodies. Platelets are emerging as key players in the pathogenesis of MG, bridging innate and adaptive immunity. We analyze platelet transcriptome signatures and their interactions with the immune system in AChR+ immunotherapy-naïve MG (nMG) patients using bulk and single-cell RNA sequencing on peripheral blood mononuclear cells (PBMC). nMG patients exhibit upregulation of genes related to activation, inflammation, and cytoskeletal regulation. Increased platelet count, activation, altered morphology, enhanced CD62P expression, and elevated plasma CD40L levels are observed in PBMCs, which diminish with minimal clinical status (MMS). Functionally, platelets show heightened interactions with leukocytes, forming aggregates that correlate with disease severity. These features return to baseline after intravenous immunoglobulin or prolonged immunosuppressive therapy. This study underscores platelet activation's critical role in MG and supports platelet-targeted therapy.

Nature CommunicationsVol. 16(1)
Shanxi Medical University (CN), Capital Medical University (CN), First Hospital of Shanxi Medical University (CN), Shandong Provincial QianFoShan Hospital (CN), Shandong First Medical University (CN)
National Natural Science Foundation of China, Beijing Jiaotong University
Openalex Percentile: Top 4%
Myasthenia Gravis and Thymoma
5.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.